65,437 trials
Arthritis, Juvenile Idiopathic
Primary: Number of Subjects in the Non-MTX Stratum With Disease Flare During the Double-Blind Phase — 13; 20 Participants — p=0.031
Infections, Gram-positive Bacterial
Primary: Clinical Response Which is Measured at Test of Cure (TOC) in the Clinically Evaluable (CE) Population — 74; 72; 3; 5 participants — p=0.5318
Hepatitis A Virus Infection
Primary: Hepatitis A Virus (HAV) Seroconversion Rate, i.e. the Percentage of Subjects Who Were Seronegative at Baseline and Developed Seropositive at Month 7 After Administration…
Psoriasis
Primary: Number of Participants With a 50% Reduction in PASI (Psoriasis Area and Severity Index) Score Compared With Baseline PASI Score (PASI50 Response) — 78; 54; 80; 55…
Tobacco Use Disorder
Primary: Smoking Abstinence at 26 Weeks — 21; 22 participants — p=>.05
Depression · Depressive Disorder
Primary: Antidepressant Response, Defined as a Hamilton Depression Rating Scale Score Relative Decrease of 50 % or More and a Final Score < 10 — 11; 11 participants
Atelectasis
Primary: Oxygen Requirement to Maintain SpO2>90% — 1; 1; 1; 1 liters per minute
Overactive Bladder
Primary: The Number of Subjects Reporting Incidence of Dry Mouth as an Adverse Event — 24; 53 participants — p=<0.0001
Pulmonary Disease, Chronic Obstructive · Major Depression
Primary: Composite Antidepressant Score Scale (CAD) — 29; 25; 9; 20 Participants
Infections, Gram-Positive Bacterial · Abscess · Burns
Primary: Clinical Response Which is Measured at Test of Cure (TOC) in the Clinically Evaluable (CE) Population — 66; 66; 6; 3 participants — p=0.5289
Osteoporosis
Primary: Percent Change From Baseline in Lumbar Spine Bone Mineral Density (BMD) at Week 52 — -0.537; -0.174; 0.309 Percent change — p=0.641
Healthy
Primary: Maximum Plasma Concentration (Cmax) for Zolpidem Tartrate — 191.94; 193.43 ng/mL
Meningitis · Meningococcal Infection
Primary: Percentage of Participants With a ≥8 Antibody Titers as Measured by Serum Bactericidal Assay Human Complement (SBA-HC) After Each Vaccination. — 38; 44; 33; 40…
Restless Legs Syndrome
Primary: Frequency Analysis for Baseline Pattern of RLS Symptoms — 0.7; 2.4; 19.3; 18.1 percentage of participants
HIV · Tuberculosis
Primary: Number of Serious Adverse Events (SAEs) — 12; 7 Events